Enorama Pharma AB (publ) (STO:ERMA)
0.770
+0.096 (14.24%)
Mar 9, 2026, 5:11 PM CET
Enorama Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -76.57 | -43.81 | -44.61 | -42.03 | -27.74 | -23.46 | Upgrade
|
| Depreciation & Amortization | -1.7 | 0.44 | 0.68 | 0.67 | 0.66 | 0.32 | Upgrade
|
| Other Amortization | 2.87 | 2.87 | 2.87 | 2.87 | 0.72 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 17.1 | 17.1 | - | - | - | - | Upgrade
|
| Other Operating Activities | 12.04 | - | - | - | - | - | Upgrade
|
| Change in Accounts Receivable | 1.74 | 0.72 | 2.26 | 4.2 | -2.6 | -2.96 | Upgrade
|
| Change in Inventory | -5.54 | -6.98 | -1.46 | -1.6 | 0.48 | -1.72 | Upgrade
|
| Change in Other Net Operating Assets | 2.3 | -6.04 | -1.09 | 2.94 | -1.68 | 4.81 | Upgrade
|
| Operating Cash Flow | -47.77 | -35.7 | -41.35 | -32.96 | -30.16 | -23 | Upgrade
|
| Capital Expenditures | - | - | - | - | -0.06 | -1.51 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -1.76 | -2.32 | Upgrade
|
| Investing Cash Flow | - | - | - | - | -1.82 | -3.84 | Upgrade
|
| Long-Term Debt Issued | - | - | 2.2 | 20 | 8 | 5.72 | Upgrade
|
| Long-Term Debt Repaid | - | -0.44 | -3.46 | -2.09 | -9.92 | -1.81 | Upgrade
|
| Net Debt Issued (Repaid) | 10.31 | -0.44 | -1.26 | 17.91 | -1.92 | 3.91 | Upgrade
|
| Issuance of Common Stock | 31.17 | 40.4 | 43.13 | 9 | 43.21 | 13.05 | Upgrade
|
| Other Financing Activities | -0.61 | -4.68 | - | -1.57 | -1.79 | - | Upgrade
|
| Financing Cash Flow | 40.87 | 35.29 | 41.86 | 25.35 | 39.51 | 16.96 | Upgrade
|
| Foreign Exchange Rate Adjustments | 3.84 | -3.65 | 1.5 | -0.45 | -0.06 | - | Upgrade
|
| Net Cash Flow | -3.05 | -4.07 | 2.01 | -8.06 | 7.47 | -9.87 | Upgrade
|
| Free Cash Flow | -47.77 | -35.7 | -41.35 | -32.96 | -30.22 | -24.51 | Upgrade
|
| Free Cash Flow Margin | -1316.01% | -226.42% | -3044.85% | -481.35% | -236.14% | -548.47% | Upgrade
|
| Free Cash Flow Per Share | -0.72 | -0.67 | -1.49 | -4.21 | -4.88 | -4.41 | Upgrade
|
| Cash Interest Paid | 9.55 | 2.99 | 3.59 | 2.09 | 0.8 | 0.45 | Upgrade
|
| Levered Free Cash Flow | -31.87 | -34.96 | -23.22 | -19.52 | -27.22 | -16.59 | Upgrade
|
| Unlevered Free Cash Flow | -25.9 | -34.69 | -22.67 | -18.72 | -26.72 | -16.31 | Upgrade
|
| Change in Working Capital | -1.5 | -12.31 | -0.28 | 5.54 | -3.8 | 0.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.